Home Noticias de Salud Family Centers Health Centers Resources My Health Manager
  Search
  PersonalMD Services  
  Family Health
  Women's Health
  Children's Health
  Men's Health
  Senior's Health
   
  Health Centers
  Alternative Medicine
  Cardiac Care Center
  Cancer Center
  Emergency Dept
  Medical Advances
  Nutrition Central
  Pulmonary Center
  Sports Medicine
  Travel Medicine
   
  Resources
  Drug Interaction
  Drugs & Medications
  Health Encyclopedia


     
   
House clears date rape drug bill

WASHINGTON, Feb 01 (Reuters Health) -- The House Monday gave final approval to legislation that would order scheduling certain drugs used in "date rapes" as federally controlled substances.

President Clinton is expected to sign the "Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act," which orders the Justice Department to act to place the drug gamma hydroxybutyric acid, also known as GHB, on Schedule I of the Controlled Substances Act. GHB has been implicated in more than 5,000 cases of abuse and some 49 deaths, including those of the two teenagers for whom the bill is named. The bill would also order the listing of GBL, a precursor substance to GHB, as a list I chemical, and would make the drug ketamine, which has also been implicated in cases of sexual abuse, a schedule III controlled substance.

"These drugs are available on the Internet," said Rep. Fred Upton, R-Mich., on the House floor. "It has to stop. This bill does that." Said Rep. Shiela Jackson-Lee, D-Texas, "I believe by classifying this drug now, we sent a strong message to those who would use this drug and its analogs to commit crimes against women and others."

Final action on the bill, different versions of which passed both the House and Senate in 1999, was complicated by the fact that while GHB has been abused, it is also in development as a treatment for a form of narcolepsy. That led to a dispute between the Drug Enforcement Administration and the Food and Drug Administration over how it should be treated. While the Justice Department wanted to subject improper use of the substance to the most severe penalties, it cannot justify such action where the substance has potential medical uses. The compromise language in the final bill would subject illegal use of GHB to Schedule I penalties, but would preserve the ability of the drug to be developed for legitimate purposes.

The bill would also require the development of model protocols for training law enforcement personnel in the detection of GHB abuse, as well as taking toxicology specimens and victim statements, because GHB is processed in the body quickly. The bill would also order the US Department of Health and Human Services to undertake a national awareness campaign about the dangers of GHB.


DISCUSSION
See what PersonalMD members have to say about this article.
 

 

 

 

Register About Us Emergency Contact us Privacy Policy Help Center
Resources Health Centers Family Health